Filter by: patients
Home > Community Treatment Reports and Side Effects > Doxorubicin liposomal Treatment Report
What is Doxorubicin liposomal?

Liposomal doxorubicin is available under the brand name Doxil®. It is an antineoplastic agent used for treatment of ovarian cancer, multiple myeloma, and AIDS-related Kaposi's sarcoma. Off label use for the treatment of metastatic breast cancer.

0 patients have reported taking Doxorubicin liposomal .

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 24, 2012.